Researchers from the Chicago College of Medicine at the University of Illinois ave identified a characteristic unique to cancer cells in an animal model of cancer ? and they believe it could be exploited as a target to develop new treatment strategies.

An enzyme that metabolizes the glucose needed for tumor growth is found in high concentrations in cancer cells, but in very few normal adult tissues. Deleting the gene for the enzyme stopped the growth of cancer in laboratory mice, with no associated adverse effects, reports Nissim Hay, professor of biochemistry and molecular genetics at the University of Illinois, and his colleagues in the August 12, 2013 issue of Cancer Cell.

Questionable Strategy
Targeting glucose metabolism for cancer therapy, while avoiding adverse effects in other parts of the body, has been a ?questionable? strategy, Hay said. But he and his coworkers showed that the glucose-metabolism enzyme hexokinase-2 or HK2 can be amost completely eliminated in adult mice without affecting normal metabolic functions or lifespan.

The glucose-metabolism enzyme hexokinase-2 can be almost completely eliminated …. without affecting normal metabolic functions.

Novasep Top 6 qualities to look for in a CDMO partner for ADCs
TRP Targeted Radiopharmaceuticals Summit
American Lung Association
Port Worthy
World ADC San Diego 2022 Novasep

Hexokinase-2 is abundant in embryos but absent in most adult cells, where related enzymes take over its role in metabolism. One of the changes that mark a cell as cancerous is expression of the embryonic enzyme. Hay and his colleagues showed that the embryonic version is required for cancer cells to proliferate and grow, and that eliminating it halts tumor growth.

Advertisement #3

They developed a mouse strain in which they could silence or delete the HK2-gene in the adult animal, and they found that these mice could not develop or sustain lung or breast cancer tumors but were otherwise normal and healthy. ?We have deleted the HK2 gene systemically in these mice, and they have been living for more than two years now. Their lifespan is the same as normal mice,? Hay said.

The researchers also looked at human lung and breast cancer cells in the lab, and found that if they eliminated all HK2, the cells stopped growing. ?We think that the process we used to delete the HK2 gene is not absolutely perfect, so there must be some low levels of HK2 in the mice. But that seems to be enough for the cells that use HK2, and the therapeutic effects on tumors in these mice are stable.?

Building blocks for DNA
According to Hay the enzyme is involved in making the building-blocks for the DNA of cancer cells, which need lots of all cellular components as they rapidly divide. ?Without HK2, the cancer cells don?t make enough DNA for new cells, and so tumor growth comes to a standstill,? said Hay.

For more information
[1] Patra KC, Wang Q, Bhaskar PT, Miller L, Wang Z, et al. Hexokinase 2 Is Required for Tumor Initiation and Maintenance and Its Systemic Deletion Is Therapeutic in Mouse Models of Cancer. 01 August 2013 Cancer Cell [Abstract]

Copyright ? 2013 InPress Media Group/Sunvalley Communication. All rights reserved. Republication or redistribution of InPress Media Group/Sunvalley Communication content, including by framing or similar means, is expressly prohibited without the prior written consent of InPress Media Group/Sunvalley Communication. InPress Media Group/Sunvalley Communication shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Onco’Zine and Oncozine are registered trademarks and trademarks of Sunvalley Communication around the world.

Advertisement #5